3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
28
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Metastatic Hormone-sensitive Prostate Cancer
1
Interventions
Surveys and Questionnaires
12
Blood Specimen Collection
12
Specimen Handling
9
Magnetic Resonance Spectroscopy
5
Radiotherapy
4
ribociclib
3
Watchful Waiting
3
Surgical Procedures, Operative
3
Standard of Care
3
Patient Reported Outcome Measures
3
Observation
3
Mental Status and Dementia Tests
3
Immune Checkpoint Inhibitors
3
Data Collection
3
Biopsy
3
trastuzumab deruxtecan
2
palbociclib
2
darolutamide
2
atezolizumab
2
X-Rays
2
Ultrasonography
2
Tomography, X-Ray Computed
2
Sulfonylurea Compounds
2
Mass Screening
2
Interviews as Topic
2
Insulin
2
Hepatectomy
2
Genetic Testing
2
Fulvestrant
2
Fluorodeoxyglucose F18
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
enzalutamide
×
30 days
×
Clear all
NCT05901649
2026-06-05
ArtemisPRO
Janssen-Cilag Ltd.
Active not recruiting
504 enrolled